FRANCY SHU: Open Payments
NPI 1437479938 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,967 in 119 payments from 32 companies in 2025. Trend: 2023 $25,841 · 2024 $22,983 · 2025 $11,967
Speaker / faculty: $3,920Consulting: $3,563Food & beverage: $2,245Travel & lodging: $2,240
| Company | Payments | Amount |
|---|---|---|
| Grifols USA, LLC | 10 | $5,066 |
| Grifols Shared Services North America, Inc. | 13 | $5,060 |
| ABBVIE INC. | 35 | $445 |
| ARGENX US, INC. | 5 | $144 |
| Genentech USA, Inc. | 4 | $120 |
| Lundbeck LLC | 5 | $103 |
| Teva Pharmaceuticals USA, Inc. | 4 | $98 |
| Axsome Therapeutics, Inc. | 3 | $86 |
| ACADIA Pharmaceuticals Inc | 3 | $84 |
| Merz Pharmaceuticals, LLC | 3 | $83 |
Products named: Gamunex-C, UBRELVY, QULIPTA, VYVGART HYTRULO, Ocrevus Zunovo, AUSTEDO XR, VYEPTI, Symbravo.
Industry payments across CA — which companies pay providers there.
